Autocrine motility factor receptor signaling pathway promotes cell invasion via activation of ROCK-2 in esophageal squamous cell cancer cells

Cancer Investigation

Volumn 28, Issue 10, 2010, Pages 993-1003

  Wang, Lili ^a   Hou, Guiqin ^b   Xue, Lexun ^a,b   Li, Jie ^b   Wei, Pan ^b   Xu, Peirong ^b  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Autocrine motility factor receptor; Esophageal squamous cell cancer; Invasion; Rho associated protein kinase 2

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; AUTOCRINE MOTILITY FACTOR RECEPTOR; COFILIN; PLASMID DNA; RHO ASSOCIATED PROTEIN KINASE 2; RHO KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UVOMORULIN; VASCULAR CELL ADHESION MOLECULE 1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL ACTIVATION; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ESOPHAGEAL SQUAMOUS CELL CANCER; ESOPHAGUS CANCER; GENETIC TRANSFECTION; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; ENZYME ACTIVATION; ESOPHAGEAL NEOPLASMS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; NEOPLASM INVASIVENESS; RECEPTORS, CYTOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; TRANSFECTION; UBIQUITIN-PROTEIN LIGASES;

EID: 78649284470     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2010.483503     Document Type: Article

References (27)

1. Katiyar, S.; Hedau, S.; Jain, N.; Kar, P.; Khuroo, M. S.; Mohanta, J.; Kumar, S.; Gopalkrishna, V.; Kumar, N.; Das, B. C. p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett 2005, 218 (1), 69-79.
2. Whibley, C. E.; Keyzers, R. A.; Soper, A. G.; Davies-Coleman, M. T.; Samaai, T.; Hendricks, D. T. Antiesophageal cancer activity from Southern African marine organisms. Ann NY Acad Sci 2005, 1056, 405-412.
3. Montesano, R.; Hollstein, M.; Hainaut, P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer 1996, 69 (3), 225-235.
4. Iiizumi, M.; Liu, W.; Pai, S. K.; Furuta, E.; Watabe, K. Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. Biochim Biophys Acta 2008, 1786 (2), 87-104.
5. Yanagawa, T.; Funasaka, T.; Tsutsumi, S.; Hu, H.; Watanabe, H.; Raz, A. Regulation of phosphoglucose isomerase/autocrine motility factor activities by the poly (ADP-ribose) polymerase family-14. Cancer Res 2007, 67 (18), 8682-8689.
6. Shimizu, K.; Tani, M.; Watanabe, H.; Nagamachi, Y.; Niinaka, Y.; Shiroishi, T.; Ohwada, S.; Raz, A.; Yokota, J. The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein. FEBS Lett 1999, 456 (2), 295-300.
7. Wang, W.; Yang, L. Y.; Yang, Z. L.; Peng, J. X.; Yang, J. Q. Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma. Dig Dis Sci 2007, 52 (3), 770-775.
8. Kawanishi, K.; Doki, Y.; Shiozaki, H.; Yano, M.; Inoue, M.; Fukuchi, N.; Utsunomiya, T.; Watanabe, H.; Monden, M. Correlation between loss of E-cadherin expression and overexpression of autocrine motility factor receptor in association with progression of human gastric cancers. Am J Clin Pathol 2000, 113 (2), 266-274.
9. Kaynak, K.; Kara, M.; Oz, B.; Akgoz, B.; Sar, M.; Raz, A. Autocrine motility factor receptor expression implies an unfavourable prognosis in resected stage I pulmonary adenocarcinomas. Acta Chir Belg 2005, 105 (4), 378-382.
10. Jiang, W. G.; Raz, A.; Douglas-Jones, A.; Mansel, R. E. Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer. J Histochem Cytochem 2006, 54 (2), 231-241.
11. Torimura, T.; Ueno, T.; Kin, M.; Harada, R.; Nakamura, T.; Kawaguchi, T.; Harada, M.; Kumashiro, R.; Watanabe, H.; Avraham, R.; Sata, M. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins. Hepatology 2001, 34 (1), 62-71.
12. Le, P. U.; Benlimame, N.; Lagana, A.; Raz, A.; Nabi, I. R. Clathrinmediated endocytosis and recycling of autocrine motility factor receptor to fibronectin fibrils is a limiting factor for NIH-3T3 cell motility. J Cell Sci 2000, 113 (Pt. 18), 3227-3240.
13. Onishi, Y.; Tsukada, K.; Yokota, J.; Raz, A. Overexpression of autocrine motility factor receptor (AMFR) in NIH3T3 fibroblasts induces cell transformation. Clin Exp Metastasis 2003, 20 (1), 51-58. (Pubitemid 36308136)
14. Tímár, J.; Rásó, E.; Döme, B.; Ladányi, A.; Bánfalvi, T.; Gilde, K.; Raz, A. Expression and function of the AMF receptor by human melanoma in experimental and clinical systems. Clin Exp Metastasis 2002, 19 (3), 225-232.
15. Tian, F.; Zang, W. D.; Hou, W. H.; Liu, H. T.; Xue, L. X. Nuclear factor-κB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA. Acta Biochim Biophys Sin 2006, 38 (5), 318-326.
16. Hou, G. Q.; Xue, L. X.; Lu, Z. M.; Fan, T. L.; Tian, F.; Xue, Y. L. An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR. Cancer Lett 2007, 253 (2), 236-248.
17. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72, 248-254.
18. Shimada, T.; Nishimura, Y.; Nishiuma, T.; Rikitake, Y.; Hirase, T.; Yokoyama, M. Adenoviral transfer of rho family proteins to lung cancer cells ameliorates cell proliferation and motility and increases apoptotic change. Kobe J Med Sci 2007, 53 (3), 125-34.
19. Rösel, D.; Brábek, J.; Tolde, O.; Mierke, C. T.; Zitterbart, D. P.; Raupach, C.; Bicanová, K.; Kollmannsberger, P.; Panková, D.; Vesely, P.; Folk, P.; Fabry, B. Up-regulation of Rho/ROCK signaling in sarcoma cells drives invasion and increased generation of protrusive forces. Mol Cancer Res 2008, 6 (9), 1410-1420.
20. Xue, F.; Takahara, T.; Yata, Y.; Xia, Q.; Nonome, K.; Shinno, E.; Kanayama, M.; Takahara, S.; Sugiyama, T. Blockade of Rho/Rhoassociated coiled coil-forming kinase signaling can prevent progression of hepatocellular carcinoma in matrix metalloproteinasedependent manner. Hepatol Res 2008, 38 (8), 810-817.
21. Vishnubhotla, R.; Sun, S.; Huq, J.; Bulic, M.; Ramesh, A.; Guzman, G.; Cho, M.; Glover, S. C. ROCK-II mediates colon cancer invasion via regulation of MMP-2 and MMP-13 at the site of invadopodia as revealed by multiphoton imaging. Lab Invest 2007, 87 (11), 1149-1158.
22. Lane, J.; Martin, T. A.; Watkins, G.; Mansel, R. E.; Jiang, W. G. The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. Int J Oncol 2008, 33 (3), 585-593.
23. Jiang, P.; Enomoto, A.; Takahashi, M. Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton. Cancer Lett 2009, 284 (2), 122-130.
24. Wang, W.; Goswami, S.; Sahai, E.; Wyckoff, J. B.; Segall, J. E.; Condeelis, J. S. Tumor cells caught in the act of invading: their strategy for enhanced cell motility. Trends Cell Biol 2005, 15 (3), 138-145.
25. Borley, A. C.; Hiscox, S.; Gee, J.; Smith, C.; Shaw, V.; Barrett-Lee, P.; Nicholson, R. I. Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells. Breast Cancer Res 2008, 10 (6), R103.
26. Kawanishi, K.; Doki, Y.; Shiozaki, H.; Yano, M.; Inoue, M.; Fukuchi, N.; Utsunomiya, T.; Watanabe, H.; Monden, M. Correlation between loss of E-cadherin expression and overexpression of autocrine motility factor receptor in association with progression of human gastric cancers. Am J Clin Pathol 2000, 113 (2), 266-274.
27. Coskun, U.; Sancak, B.; Sen, I.; Bukan, N.; Tufan, M. A.; Gülbahar, O.; Sozen, S. Serum P-selectin, soluble vascular cell adhesion molecule-I (s-VCAM-I) and soluble intercellular adhesion molecule-I (s-ICAM-I) levels in bladder carcinoma patients with different stages. Int Immunopharmacol 2006, 6 (4), 672-677.